Zafgen Revenue 2012-2019 | ZFGN

Zafgen revenue from 2012 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Zafgen Annual Revenue
(Millions of US $)
2018 $
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
Zafgen Quarterly Revenue
(Millions of US $)
Q3 2019
Q2 2019
Q1 2019
Q4 2018
Q3 2018
Q2 2018
Q1 2018
Q4 2017
Q3 2017
Q2 2017
Q1 2017
Q4 2016
Q3 2016
Q2 2016
Q1 2016
Q4 2015
Q3 2015
Q2 2015
Q1 2015
Q4 2014
Q3 2014
Q2 2014
Q1 2014
Q4 2013
Q3 2013
Q2 2013
Q1 2013
Q4 2012
Q4 2011
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.031B $0.000B
Zafgen, Inc. is a biopharmaceutical company. The Company develops therapeutics for patients suffering from obesity and obesity-related disorders. Its lead product candidate includes Beloranib, an injection that is in Phase II clinical trials for the treatment of various indications comprising obesity and hyperphagia in Prader-Willi Syndrome patients, craniopharyngioma-associated obesity, and severe obesity in the general population. Zafgen, Inc. is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $63.808B 10.08
Zoetis (ZTS) United States $57.032B 34.11
Astellas Pharma (ALPMY) Japan $31.827B 15.90
Eisai (ESALY) Japan $20.681B 39.88
UCB SA (UCBJF) Belgium $15.697B 0.00
Grifols, S.A (GRFS) Spain $15.415B 20.20
Merck (MKGAF) Germany $14.688B 20.04
Neurocrine Biosciences (NBIX) United States $10.920B 515.52
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $9.301B 0.00
Ionis Pharmaceuticals (IONS) United States $9.143B 18.52
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.382B 10.70
Sage Therapeutics (SAGE) United States $7.732B 0.00
Catalent (CTLT) United States $7.576B 30.82
Arrowhead Pharmaceuticals (ARWR) United States $6.361B 96.32
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.263B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $4.846B 17.42
FibroGen (FGEN) United States $4.082B 119.95
United Therapeutics (UTHR) United States $4.008B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.650B 13.34
Nektar Therapeutics (NKTR) United States $3.570B 0.00
Evotec AG (EVTCY) Germany $3.226B 52.78
PTC Therapeutics (PTCT) United States $3.086B 0.00
Heron Therapeutics (HRTX) United States $2.382B 0.00
Xencor (XNCR) United States $2.301B 69.95
Portola Pharmaceuticals (PTLA) United States $2.205B 0.00
Zogenix (ZGNX) United States $2.071B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.932B 57.16
Ironwood Pharmaceuticals (IRWD) United States $1.929B 61.50
Tilray (TLRY) Canada $1.886B 0.00
ChemoCentryx (CCXI) United States $1.630B 0.00
USANA Health Sciences (USNA) United States $1.609B 17.17
Corcept Therapeutics (CORT) United States $1.501B 18.24
Endo (ENDP) Ireland $1.248B 2.29
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.239B 28.28
Theravance Biopharma (TBPH) Cayman Islands $1.225B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.211B 8.27
Karyopharm Therapeutics (KPTI) United States $1.133B 0.00
ArQule (ARQL) United States $1.123B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.070B 0.00
Radius Health (RDUS) United States $1.003B 0.00
Aerie Pharmaceuticals (AERI) United States $0.940B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.791B 0.00
Akebia Therapeutics (AKBA) United States $0.714B 0.00
Flexion Therapeutics (FLXN) United States $0.709B 0.00
Collegium Pharmaceutical (COLL) United States $0.692B 0.00
TherapeuticsMD (TXMD) United States $0.659B 0.00
ImmunoGen (IMGN) United States $0.599B 0.00
Translate Bio (TBIO) United States $0.597B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.478B 58.00
Molecular Templates (MTEM) United States $0.471B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.470B 0.00
Organogenesis Holdings (ORGO) United States $0.457B 0.00
Harpoon Therapeutics (HARP) United States $0.443B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.440B 0.00
Dermira (DERM) United States $0.437B 0.00
Ardelyx (ARDX) United States $0.429B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.418B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.407B 17.55
DURECT (DRRX) United States $0.396B 0.00
Indivior (INVVY) United States $0.393B 1.42
Recro Pharma (REPH) United States $0.379B 0.00
Concordia (CXRXF) Canada $0.374B 0.00
OptiNose (OPTN) United States $0.370B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.359B 0.00
Innate Pharma SA (IPHYF) France $0.358B 0.00
Siga Technologies (SIGA) United States $0.357B 8.15
Lannett Co Inc (LCI) United States $0.349B 4.06
Corbus Pharmaceuticals Holdings (CRBP) United States $0.329B 0.00
Rafael Holdings (RFL) United States $0.286B 0.00
KalVista Pharmaceuticals (KALV) United States $0.266B 0.00
GlycoMimetics (GLYC) United States $0.264B 0.00
Jounce Therapeutics (JNCE) United States $0.263B 3.51
Calithera Biosciences (CALA) United States $0.252B 0.00
Xeris Pharmaceuticals (XERS) United States $0.241B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.229B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.222B 0.00
Aquestive Therapeutics (AQST) United States $0.220B 0.00
Ocular Therapeutix (OCUL) United States $0.196B 0.00
Nature's Sunshine Products (NATR) United States $0.190B 32.73
Foamix Pharmaceuticals (FOMX) Israel $0.189B 0.00
Concert Pharmaceuticals (CNCE) United States $0.181B 0.00
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
MEI Pharma (MEIP) United States $0.147B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.146B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.145B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.142B 0.00
IMV INC (IMV) Canada $0.140B 0.00
Redhill Biopharma (RDHL) Israel $0.139B 0.00
CannTrust Holdings (CTST) Canada $0.110B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Cardiome Pharma (CORV) Canada $0.102B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.100B 0.00
CV Sciences (CVSI) United States $0.099B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.091B 0.00
Champions Oncology (CSBR) United States $0.081B 0.00
MediWound (MDWD) Israel $0.080B 0.00
PolarityTE (PTE) United States $0.080B 0.00
Otonomy (OTIC) United States $0.079B 0.00
Neos Therapeutics (NEOS) United States $0.079B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.078B 23.45
Infinity Pharmaceuticals (INFI) United States $0.072B 0.00
Aclaris Therapeutics (ACRS) United States $0.070B 0.00
Capnia (SLNO) United States $0.068B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.066B 0.00
Pharmaxis (PXSLY) Australia $0.065B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.059B 0.00
Genocea Biosciences (GNCA) United States $0.059B 0.00
Novan (NOVN) United States $0.057B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.056B 0.00
SCYNEXIS (SCYX) United States $0.056B 0.00
Natural Alternatives (NAII) United States $0.056B 13.93
Nivalis Therapeutics (ALPN) United States $0.056B 0.00
Medicure (MCUJF) Canada $0.054B 0.00
CTI BioPharma (CTIC) United States $0.053B 0.00
RENEURON GP (RNUGF) United Kingdom $0.052B 0.00
IntelGenx Technologies (IGXT) Canada $0.052B 0.00
ElectroCore (ECOR) United States $0.051B 0.00
Mast Therapeutics (SVRA) United States $0.049B 0.00
AgeX Therapeutics (AGE) United States $0.047B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.047B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.042B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.041B 0.00
IsoRay (ISR) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Opexa Therapeutics (ACER) United States $0.037B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.035B 0.00
PharmAthene (ALT) United States $0.033B 0.00
Jaguar Animal Health (JAGX) United States $0.031B 0.00
Biomerica (BMRA) United States $0.029B 0.00
India Globalization Capital (IGC) United States $0.029B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.027B 0.00
ProPhase Labs (PRPH) United States $0.025B 0.00
Bio-Path Holdings (BPTH) United States $0.024B 0.00
Melinta Therapeutics (MLNT) United States $0.023B 0.00
Shineco (TYHT) China $0.023B 0.00
China SXT Pharmaceuticals (SXTC) China $0.022B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
VAXART, INC (VXRT) United States $0.015B 0.00
Heat Biologics (HTBX) United States $0.015B 0.00
Vical (BBI) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Lipocine (LPCN) United States $0.011B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Achieve Life Sciences (ACHV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Can-Fite Biopharma (CANF) Israel $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Hemispherx BioPharma (AIM) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Forward Pharma (FWP) Denmark $0.000B 0.00